Cellular density and cell type are the key factors in growth inhibition induced by 2,5Bis [1-aziridinyl]-1,4 benzoquinone (DZQ)

Anticancer Research

Volumn 26, Issue 5 A, 2006, Pages 3535-3540

  Córdoba Pedregosa, María Del Carmen ^a   Villalba, José M ^a   González Aragón, David ^a   Bello, Rosario I ^a   Alcaín, Francisco J ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Antitumor quinone; Catalase; Cell density; HeLa cells; HepG2 cells; NAD(P)H:quinone oxidoreductase 1

Indexed keywords

ANTIOXIDANT; AZIRIDINYLBENZOQUINONE; CATALASE; POLYCLONAL ANTISERUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CELL DENSITY; CELL TYPE; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY;

AZIRIDINES; BENZOQUINONES; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CATALASE; CELL COUNT; CELL PROLIFERATION; CYTOSOL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATIVE STRESS; TUMOR CELLS, CULTURED;

EID: 33750685300     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ernster L and Navazio F: Soluble diaphorase in animal tissues. Acta Chem Scand 12: 595-602, 1958.
2. Siegel D and Ross D: Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Rad Biol Med 29: 246-253, 2000.
3. Jaiswal AK: Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Rad Biol Med 29: 254-262, 2000.
4. Cadenas E: Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol 49: 127-140, 1995.
5. Lind C, Cadenas E, Hochstein P and Ernster L: DT-diaphorase: purification, properties, and function. Methods Enzymol 186: 287-301, 1990.
6. Li R, Bianchet MA, Talalay P and Amzel LM: The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc Natl Acad Sci USA 92: 8846-8850, 1995.
7. Faig M, Bianchet MA, Talalay P, Chen S, Winski S, Ross D and Amzel LM: Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release. Proc Natl Acad Sci USA 97: 3177-3182, 2000.
8. Lind C, Hochstein P and Ernster L: DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide formation. Arch Biochem Biophys 216: 178-185, 1982.
9. Radjendirane V, Joseph P and Jaiswall AK: Gene expression of DT diaphorase (NQO1) in cancer cells. In: Oxidative Stress and Signal Transduction. Forman HJ and Cadenas E (eds.). Chapman and Hall, New York, pp. 441-475, 1997.
10. Schlager JJ, Hoerl BJ, Riebow J, Scott DP, Gasdaska P, Scott RE and Powis G: Increased NAD(P)H:(quinone-acceptor) oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells. Cancer Res 53: 1338-1342, 1993.
11. Collin P, Lomri A and Marie PJ: Expression and activity of NAD(P)H:quinone oxidoreductase (NMO1) in human osteoblastic cells. Bone 28: 9-13, 2001.
12. Bello RI, Gómez-Díaz C, Navarro, F, Alcaín FJ and Villalba JM: Expression of NAD(P)H:quinone oxidoreductase 1 in HeLa cells. Role of hydrogen peroxide and growth phase. J Biol Chem 276: 44379-44384, 2001.
13. Cresteil T and Jaiswal AK: High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of same origin. Biochem Pharmacol 42: 1021-1027, 1991.
14. Belinsky M and Jaiswal AK: NAD(P)H:quinone oxidoreductase 1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 12: 103-107, 1993.
15. 5 reductase in human lung and breast tumours. Brit J Cancer 76: 923-929, 1997.
16. Dinkova-Kostova AT and Talalay P: Persuasive evidence that quinone reductase type I (DT-diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Rad Biol Med 29: 231-240, 2000
17. Moran JL Siegel D and Ross D: A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA 96: 8150-8155, 1999.
18. Bauer AK, Faiola B, Abernethy DJ, Marchan R, Pluta LJ, Wong VA, Roberts K, Jaiswal AK, Gonzalez FJ, Butterworth BE, Borgoff, S, Parkinson H, Everitt L and Recio L: Genetic susceptibility to bencen-induced toxicity: role of NADP:quinone oxidoreductase 1. Cancer Res 63: 929-935, 2003.
19. Lafuente MJ, Casterad X, Trias M, Ascaso C, Molina R, Ballesta A, Zheng S, Wiewncke JK and Lafuente A: NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis 21: 1813-1819, 2000.
20. Lewis SJ, Cherry NM, Niven RM, Barber, PV and Povey AC: Polymorphisms in the NAD(P)H:quinone oxidoreductase gene and small cell lung cancer risk in the UK population. Lung Cancer 34: 177-183, 2001.
21. Park SJ, Zhaoa H, Spitz MR, Grossman HB and Wu X: An association between NQO1 genetic polymorphism and risk of bladder cancer. Mut Res 536: 131-137, 2003.
22. Ross D, Kepa JK, Winski SL, Bweall HD, Anwar A and Siegel D: NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Inter 129: 77-97, 2000.
23. Winski SL, Swann E, Hargreaves RHJ, Dehn DL, Butler J, Moody CJ and Ross D: Relationship between NAD(P)H: quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol 61: 1509-1516, 2001.
24. Phillips RM, de la Cruz A, Traver RD and Gibson NW: Increased activity and expression of NAD(P)H:quinone acceptor oxidoreductase in confluent cell cultures and whitin multicellular spheroids. Cancer Res 54: 3766-3771, 1994.
25. Brar SS, Kennedy TP, Whorton AR, Murphy TM, Chitano P and Hoidal JR: Requirement for reactive oxygen species in serum-induced and platelet-derived growth factor-induced growth of airway smooth muscle. J Biol Chem 274: 20017-20026, 1999.
26. Stoscheck CM: Quantitation of protein. Methods Enzymol 182: 50-68, 1990.
27. Qiu X and Cadenas E: The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells. Arch Biochem Biophys 346: 241-251, 1997.
28. Edlund C, Elhammer A and Dallner G: Distribution of newly synthesized DT-diaphorase in rat liver. Biosci Rep 2: 861-865, 1982.
29. Winski SL, Koutalos Y, Bentley DL and Ross D: Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells. Cancer Res 62: 1420-1424, 2002.
30. De Haan LHJ, Boerboom AMJF, Rietjens IMCM, van Capelle D, De Ruijter AJM, Jaiswal AK and Aarts JMMJG: A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells. Biochem Phermacol 64: 1597-1603, 2002.
31. Gibson NW, Hartley JA, Butler J, Siegel D and Ross D: Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity. Mol Pharmacol 42: 531-536, 1992.
32. Bello RI, Alcaín RI, Gómez-Daz C, López-Lluch G, Navas P and Villalba JM: Hydrogen peroxide and cell density-regulated expression of cytochrome b5 reductase in HeLa cells. J Bioenerg Biomembr 55: 169-179, 2003.
33. Doostdar H, Demoz A, Burke MD, Melvin WT and Grant MH: Variation in drug-metabolizing enzyme activity during the growth of human HepG2 hepatoma cells. Xenobiotica 20: 435-441, 1990.
34. Qiu, X Forman J, Schönthal AH and Cadenas E: Induction of p21 mediated by reactive oxygen species formed during metabolism of aziridinylbenzoquinones by HCT1 16 cells. J Biol Chem 271: 31915-31921, 1996.
35. Bai J and Cederbaum AI: Catalase protects HepG2 cells from apoptosis induced DNA-damaging agents by accelerating the degradation of p53. J Biol Chem 278: 4660-4667, 2003.
36. Smitskamp-Wilms E, Giaccone G, Pinedo HM, van der Laan BF and Peters GJ: DT-diaphorase activity in normal and neoplastic human tissue; an indicator for sensitivity to bioreductive agents? Br J Cancer 72: 917-921, 1995.